Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Mild cognitive impairment
Psychiatry · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
!
A new cognitive change is not mild cognitive impairment
Hours-to-days inattention, altered arousal, focal neurology, seizure, severe headache, head injury, hypoglycaemia, hypoxia or systemic illness requires an acute delirium, stroke or medical pathway rather than a stable MCI label.
Action: Assess ABCDE, glucose, observations, attention, onset and focal neurology; obtain the previous baseline from someone who knows the person; treat immediate physiological threats; and arrange urgent medical or stroke assessment when indicated. Defer stable cognitive classification until the acute disturbance has resolved.
Overview
Identify objective cognitive decline that has not removed everyday independence, investigate acute and treatable contributors, explain uncertainty without minimising symptoms, and arrange proportionate risk reduction and longitudinal reassessment.
Mild cognitive impairment is a clinical syndrome between subjective concern and dementia, but it is not an inevitable stage on a one-way path. The person has evidence of decline in memory, language, attention, executive, visuospatial or social cognition, yet remains broadly independent in everyday activities. They may use lists, reminders or extra time. The distinction from dementia depends on real-world functional interference, not a particular score. Describe which domain is affected and how evidence was obtained rather than treating the acronym as an aetiological diagnosis.
Start with chronology. Ask what changed, when it began, whether progression is steady, stepwise or fluctuating, and what happened around illness, bereavement, retirement or medicine changes. Examples such as repeating a question, losing a familiar route, failing a previously routine financial task or struggling to sequence a meal are more informative than saying memory is poor. With consent, seek collateral information because impaired insight and anxious over-reporting are both possible. Explore education, language, occupation and prior ability so that assessment is neither culturally nor intellectually miscalibrated.
Aetiology
01
Neurodegenerative change
Early Alzheimer's, Lewy-body, frontotemporal or related disease may impair a specific network before dependence is evident, but phenotype and progression remain heterogeneous.
02
Cerebrovascular injury
Strategic infarction and small-vessel disease can reduce processing, executive and memory efficiency alone or together with degenerative pathology.
03
Medical and psychiatric contributors
Depression, sleep disorder, substances, sensory loss, endocrine or nutritional disturbance and medicine burden can cause or amplify measurable cognitive difficulty.
Pathophysiology
1
Reduced network reserve
Synaptic, vascular or systemic stress reduces cognitive efficiency while compensatory strategies still sustain most independent activity.
2
Domain-selective disruption
Memory, language, executive, visuospatial or attentional networks can be affected unevenly, allowing a global screening total to conceal meaningful decline.
3
Compensation and demand
Lists, routines and environmental support offset impairment until illness or task complexity exceeds reserve and reveals functional difficulty.
Clinical features and red flags
Objective domain decline
History and adapted cognitive assessment support a decline in memory, executive, language, attention, visuospatial or social-cognitive performance beyond expected variation.
Broadly preserved independence
Complex tasks remain possible, sometimes with new compensatory strategies or extra effort, without clear dementia-level dependence or unsafe failure.
Subjective cognitive concern
The person notices decline but objective evidence is absent or uncertain, prompting assessment of mood, sleep, health and longitudinal change rather than dismissal.
Progressive functional transition
New inability to manage medicines, money, travel, cooking or communication safely suggests movement beyond MCI and requires diagnostic reassessment.
Non-amnestic profile
Executive, language or visuospatial decline can dominate even when brief memory testing is reassuring and deserves appropriately adapted specialist assessment.
Acute cognitive syndrome
Fluctuating attention or arousal over hours or days is delirium or another acute neurological process, not uncomplicated MCI.
Red flags requiring action
Abrupt or fluctuating inattention, drowsiness or agitation indicates possible delirium and needs same-day physiological assessment and cause treatment.
Sudden facial, arm, speech, visual or balance deficit requires emergency stroke assessment from the last-known-well time.
Investigations
01Person and collateral historyFirst step
Why
Define domain, onset, trajectory, compensatory strategies, daily function and safety using concrete examples.
Interpretation and limitations
Objective decline with preserved independence supports MCI, while new dependence or an acute fluctuating course changes the diagnostic pathway.
02Adapted cognitive assessment
Why
Sample several cognitive domains with a validated instrument suited to language, literacy and sensory ability.
Interpretation and limitations
Interpret error pattern and prior ability; neither a normal nor a low total independently establishes the syndrome or cause.
Treat psychiatric contributors while continuing follow-up when objective progressive change remains plausible.
04Physical and neurological examination
Why
Look for delirium physiology, focal signs, parkinsonism, gait disorder, sensory loss and systemic illness.
Interpretation and limitations
Acute or rapidly progressive findings require urgent pathways; chronic abnormalities guide targeted referral and testing.
05
Differential diagnosis
01
Subjective cognitive decline
Concern is present without reproducible objective impairment, requiring contextual assessment and follow-up rather than automatic disease labelling.
02
Dementia
Cognitive decline interferes with independent everyday function beyond compensatory effort and prompts full diagnostic and support planning.
03
Delirium
Acute fluctuating attention or arousal reflects physiological brain dysfunction requiring immediate assessment, even when chronic cognitive concern also exists.
04
Depression and anxiety
Mood, sleep, motivation and threat-focused attention can impair performance, while psychiatric and neurodegenerative disorders may coexist.
05
Functional cognitive disorder
Positive internal inconsistencies may support altered attention and beliefs rather than degeneration, but formulation requires specialist care and respectful explanation.
Management
01Acute changeStabilise before cognitive classificationFirst stepAttention, arousal, cognition or neurological function changes over hours or days.+
1Assess ABCDE, glucose, observations, focal neurology and immediate risk while obtaining the last reliable baseline.
2Treat delirium, stroke, seizure, infection, trauma or metabolic causes through the appropriate urgent pathway.
3Reassess cognition and everyday function after recovery rather than carrying an acute MCI label forward.
02Stable concernEstablish cognition and independencePersistent cognitive change is reported without an acute physiological or neurological emergency.+
1Take person and consent-based collateral histories, examine function, mood, sleep, substances, senses, medicines and physical health.
2Use an adapted validated cognitive instrument and targeted investigations, referring for specialist or neuropsychological assessment when needed.
Complications
01
Progression to dependence
Underlying brain disease may advance until medication, financial, navigation and self-care activities are no longer managed safely.
02
Anxiety and stigma
Catastrophic interpretation or dismissive reassurance can both intensify distress, reduce activity and damage confident future help-seeking.
03
Hidden safety failure
Driving, scams, medication error, cooking incidents and getting lost may emerge before basic personal care visibly deteriorates.
04
Iatrogenic harm
Unnecessary dementia medicines, abrupt deprescribing or excessive testing can cause adverse effects without resolving diagnostic uncertainty.
Monitoring and follow-up
Record domain-specific cognition and concrete daily activities so later reviews compare meaningful change rather than vague impressions.
Review medicines for anticholinergic and sedative burden, documenting indication, staged changes, withdrawal risk and subsequent cognition.
Track mood, sleep, alcohol, hearing, vision, cardiovascular factors, falls, nutrition and physical activity alongside cognitive findings.
Ask about driving incidents, missed medicines, financial errors, scams, cooking problems, getting lost and new reliance on others.
Escalate acute fluctuation, focal signs, seizure, rapid progression, psychosis, suicidality or severe self-neglect without waiting for routine review.
Revisit consent for collateral involvement and provide accessible written results, uncertainty, follow-up timing and return triggers.
Special situations
Function is not binary
New compensatory strategies can preserve independence, while hidden transfer of complex tasks may reveal clinically important loss that a basic-activities checklist misses.
One score is provisional
Premorbid ability, language, education, anxiety, sensory loss and test conditions influence totals, so domain pattern and longitudinal function remain essential.
Stability is informative
A non-progressive course after contributor treatment may reshape the formulation, but continued concern deserves proportionate review rather than permanent reassurance.
Planning can preserve autonomy
Early discussion of support, preferences and legal planning can expand future choice without implying that current decision-making capacity has disappeared.
Risk reduction has wider value
Physical activity, cardiovascular treatment, sleep care and sensory correction are worthwhile for established health and functional benefits even when cognitive prognosis stays uncertain.
Common pitfalls
01
Calling an hours-to-days confusional state MCI and delaying assessment for delirium, stroke or another acute cause.
02
Equating a normal short screen with normal cognition despite progressive domain-specific or functional evidence.
03
Describing all memory lapses as MCI without objective decline, contextual assessment or longitudinal corroboration.
04
Assuming basic self-care proves preserved independence while a relative has quietly taken over money, medicines and travel.
05
Promising inevitable dementia or guaranteed recovery when individual prognosis is uncertain and causes may be mixed.
06
Starting a cholinesterase inhibitor or memantine solely for an MCI label without a supported dementia indication.
07
Treating one abnormal blood result as the complete explanation and ending surveillance despite continuing progression.
08
Removing decision-making or driving autonomy because of a diagnostic term rather than assessing the specific ability and risk.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
PsychiatryOriginal SBA
MCI functional boundary
A retired teacher reports gradually slower recall and uses detailed lists, but still manages medicines, finances, travel and cooking safely without another person's help. Testing confirms decline from prior ability. Which feature most supports MCI rather than dementia?
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.
NICE NG97 dementia recommendationsPerson and collateral assessment, cognitive tools, function, contributors, referral, imaging and post-diagnostic principles relevant when dementia is a concern.
Function needs granular testing. A person may still wash and dress but have transferred bills to a partner after errors, stopped cooking after fires or abandoned unfamiliar journeys. That can represent meaningful dependence despite preserved basic activities. Conversely, choosing online banking assistance or using a diary does not itself prove dementia. Ask whether support is new, why it became necessary and whether tasks are completed safely. Assess driving, medicines, appointments, money, work, caring responsibilities, nutrition and vulnerability without presuming incapacity.
An acute change is delirium until assessed otherwise. Establish attention and arousal, examine for illness and obtain a baseline. Depression, anxiety, grief, insomnia, sleep apnoea, alcohol, pain, hearing or visual loss and medicines with anticholinergic or sedative effects can impair cognition. Thyroid disease, B12 or folate deficiency, metabolic disturbance and organ failure are selected for testing from history and examination. Treating a contributor may improve function, but improvement or one abnormal result does not exclude coexisting neurodegenerative disease.
Use a validated brief cognitive instrument adapted to language, literacy, hearing, vision and motor ability. Record the instrument and test conditions. Examine the domain pattern and errors rather than only the total. A normal result cannot override persuasive progressive functional evidence, particularly in a person with high prior ability or a focal executive, language or visuospatial syndrome. A low score may reflect education, sensory barriers, anxiety or delirium. Formal neuropsychological assessment is useful when objective impairment, profile or functional interpretation remains uncertain.
Physical and neurological examination looks for parkinsonism, focal deficit, gait disorder, eye-movement abnormalities, neuropathy and systemic disease. Appropriate laboratory tests and structural imaging follow the clinical question rather than a universal MCI panel. Image urgently for acute neurology or trauma; use a specialist cognitive pathway when structural disease or subtype clarification is relevant. Progressive symptoms with seizures, myoclonus, ataxia or unusually rapid loss require expedited neurology rather than routine surveillance.
Explain prognosis honestly. MCI can remain stable, improve after contributors are addressed or progress to dementia; group conversion estimates cannot predict one person. Avoid both false reassurance and catastrophic language. Give a written account of the current formulation, uncertainties, treated contributors and return triggers. Discuss driving according to current functional risk and jurisdictional rules, not the label alone. Capacity remains decision-specific, and planning support should enhance autonomy rather than remove it pre-emptively.
Management is directed at cause, resilience and safety. Rationalise anticholinergic and sedating medicines through a staged prescriber-led plan; correct sensory problems and clinically significant deficiencies; treat depression and sleep disorder; and optimise blood pressure, lipids, diabetes, smoking and alcohol for established health indications. Encourage regular physical activity and meaningful social and cognitive engagement adapted to ability. Do not prescribe unproven supplements or dementia medicines merely to make the uncertainty feel treated.
Follow-up should be individualised to concern, trajectory, aetiology and risk. Review sooner after medicine changes, depression treatment or acute illness, and promptly for new functional loss or neurological signs. At planned review, compare concrete activities, cognition, mood, sleep, sensory function, physical health and collateral observations under similar conditions. Repeating a score too frequently can magnify practice effects and measurement noise. Escalate to a specialist dementia service when progressive cognitive change remains suspected or functional impact emerges.
Key points
MCI describes measurable decline in one or more cognitive domains with broadly preserved independence and insufficient functional impact for dementia; it is a syndrome, not a single disease.
Ask the person and, with consent, someone who knows them for concrete changes in memory, language, executive, visuospatial and social-cognitive tasks over time.
Separate ordinary lapses from repeated decline, but do not use age, one normal screen or high premorbid ability to dismiss a consistent history.
Exclude delirium first and assess depression, sleep, alcohol, medicines, hearing, vision, endocrine, nutritional, vascular and neurological contributors.
Use an adapted validated cognitive instrument to describe domains; the score neither establishes aetiology nor reliably predicts an individual's progression.
Daily function is the critical boundary: examine complex tasks closely and distinguish compensatory strategies from loss of independence.
Not everyone with MCI develops dementia; some remain stable or improve, while others have an underlying neurodegenerative or vascular process.
There is no general indication to start donepezil, rivastigmine, galantamine or memantine simply because MCI has been recorded.
Optimise cardiovascular health, physical activity, sleep, sensory function, medication burden and meaningful cognitive and social activity for their broader benefits.
Getting lost, unsafe driving, missed essential medicines, financial exploitation or recurrent kitchen incidents may show that independence is no longer preserved.
Suicidal thinking, profound self-neglect, psychosis or severe depressive biological symptoms needs urgent mental-health and safety assessment rather than attribution to cognition.
A coercive relative, unexplained transactions, injury or neglect raises a safeguarding concern even when the person appears to agree.
Targeted laboratory assessment
Why
Investigate metabolic, endocrine, nutritional, infectious and organ contributors selected from clinical context.
Interpretation and limitations
Correct clinically relevant abnormalities and reassess, recognising that contributors may coexist with neurodegenerative disease.
06Structural imaging or neuropsychology
Why
Clarify structural disease, objective impairment or domain profile when uncertainty would alter diagnosis or care.
Interpretation and limitations
Specialist tests support a longitudinal formulation and should not be interpreted as standalone proof of MCI or dementia.
3Classify the current syndrome transparently, document uncertainties and address contributors, safety and modifiable health risks.
03Longitudinal reviewDetect change without score chasingMCI or unresolved objective cognitive decline has been identified after initial assessment.+
1Agree a proportionate review interval and earlier triggers such as getting lost, medication errors, falls, acute confusion or neurological signs.
2Compare daily activities, collateral examples, cognition, mood, sleep, sensory status and physical health under similar testing conditions.
3Refer or re-refer to a dementia or neurology service when function declines, progression accelerates or the phenotype becomes diagnostically informative.
Agree a review interval and earlier-return triggers, repeating function, mood, cognition and safety rather than chasing small score changes in isolation.